Cases & Deals

Celgene files patent suit against KV Pharmaceuticals over generic version of Focalin XR®

Clients Celgene Corporation

Jones Day represented Celgene Corporation in a Hatch-Waxman patent infringement action concerning ADHD drug product Focalin XR®.

Celgene Corporation, et al. v. KV Pharmaceutical Company, Case No. 3-08-cv-06247 (D.N.J.) (Judge Wolfson)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.